| Quarterly Financials | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Jun 2025 | Sept 2025 |
Revenue  | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 5 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| EBITDA | 0 | -2 | -1 | -1 | -0 | -1 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -5 |
| Operating Profit % | 0 % | -122 % | -164 % | -171 % | -110 % | -221 % | -3,100 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -2 | -1 | -1 | -0 | -1 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -5 |
| Tax | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 |
| Net Profit | 0 | -2 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -5 |
| EPS in ₹ | 0.00 | 0.00 | -0.42 | -0.36 | -0.28 | -0.26 | -0.19 | -0.19 | -0.13 | 0.09 | -0.03 | -0.02 | 0.00 | -2.00 |
Samsrita Labs
Samsrita Labs
22.68
+0.29
(1.30%)
Key Fundamentals
Market Cap
50.90 Cr
EPS
-0.19
PE Ratio
-174.46
Dividend Yield
0.00 %
Industry
Healthcare Services 52 Week High
26.04
52 Week Low
12.19
PB Ratio
2.59
Debt to Equity
0.19
Sector
Healthcare Service Provider Actual
Company News
View All News
Samsrita Labs Limited announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The company acquired a patent on 'Drug Conjugated Ultra-Small Gold Nanoparticle for Effective Killing of Drug-Resistant Cancer Cells' from Centre for Liver Research and Diagnostics for Rs 2 crores plus taxes, paid through adjustment of existing deposits. During the quarter, the company raised funds through preferential issue of 33.91 lakh equity shares at Rs 10 each to non-promoters and issued 45.50 lakh equity shares to promoters of QROPS Advisory Services Pvt Ltd under a share-swap arrangement, acquiring a 28.62% stake. The company wrote off advances of Rs 2.59 crores with Centre for Liver Research and Diagnostics against COVID-19 related pending claims and provided Rs 2.09 crores provision for bad debt from debtor Mangal Savitri Bizcon Private Limited. QROPS became an associate company with its profits now incorporated into consolidated financial statements.
Samsrita Labs Appoints Mrs. M. Gita Usha Rani as Company Secretary and Compliance Officer
Sep 08, 2025
Sep 08, 2025Samsrita Labs Limited appointed Mrs. M. Gita Usha Rani as Company Secretary and Compliance Officer effective September 8, 2025. The Board of Directors approved the appointment during their meeting held on the same date from 3:30 p.m. to 5:00 p.m. at the company's registered office. Mrs. Rani is a qualified Company Secretary with over 8 years of experience in secretarial work. She holds no shareholding in the company and has no relationships with other directors. Her appointment terms follow the existing norms for Key Managerial Personnel of the company.
Four members of the Basaboini family acquired a combined 15,00,000 equity shares (6.6% stake) in Samsrita Labs Limited through preferential allotment on July 18, 2025. Basaboini Malathi and Mallikarjun Rao Basaboini each acquired 5,00,000 shares (2.20% each), while Mrinalini Basaboini and Mriganayani Basaboini each acquired 2,50,000 shares (1.10% each). The acquisition was made on a cash basis through preferential issue. The acquirers do not belong to the promoter group and had no previous holdings in the company. Post-acquisition, Samsrita Labs' total equity share capital stands at 2,27,49,710 shares of Rs. 10 each. The company's shares are listed on BSE Limited and Metropolitan Stock Exchange of India Limited.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,080.70 | #1 25,669.70 | 47.78 | #1 2,554.80 | 11.28 | #1 492 | 16.36 | 45.18 | |
1,023.85 | 10,458.40 | 69.29 | 699.70 | 23.06 | 144 | 2.85 | 56.06 | |
1,974.70 | 10,133.00 | 64.34 | 1,346.30 | 10.64 | 146 | 13.28 | 48.77 | |
1,399.30 | 7,342.90 | 58.60 | 702.20 | 20.80 | 91 | 81.06 | 62.93 | |
808.50 | 2,664.40 | 31.04 | 742.70 | 16.70 | 78 | 22.45 | 53.11 | |
309.30 | 1,634.60 | 51.69 | 255.90 | 15.11 | 31 | -13.73 | 46.72 | |
1,361.20 | 1,211.00 | 23.82 | 111.60 | 28.72 | 48 | 11.50 | 47.76 | |
289.55 | 891.80 | #1 -6.21 | 1,170.80 | -18.47 | -134 | -35.12 | 42.17 | |
412.25 | 854.30 | 30.33 | 147.80 | #1 134.60 | 19 | #1 444.44 | 69.03 | |
135.00 | 94.90 | 63.11 | 41.80 | 13.28 | 2 | 0.00 | 35.55 |
Growth Rate
Revenue Growth
-100.00 %
Net Income Growth
50.00 %
Cash Flow Change
-76.92 %
ROE
6.37 %
ROCE
6.44 %
EBITDA Margin (Avg.)
-100.00 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 19 | 23 | 26 | 28 | 17 | 17 | 16 | 16 | 16 |
| Fixed Assets | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3 | 4 | 6 | 7 | 7 | 7 | 6 | 6 | 6 |
| Capital Work in Progress | 15 | 16 | 18 | 19 | 3 | 3 | 3 | 3 | 3 |
| Investments | 0 | 0 | 0 | 0 | 4 | 5 | 5 | 5 | 5 |
| Other Assets | 4 | 6 | 8 | 9 | 9 | 9 | 8 | 8 | 8 |
| Total Liabilities | 19 | 23 | 26 | 28 | 17 | 17 | 16 | 16 | 16 |
| Current Liabilities | 7 | 7 | 10 | 12 | 5 | 4 | 3 | 3 | 4 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 12 | 16 | 16 | 16 | 11 | 13 | 13 | 12 | 12 |
| Reserve & Surplus | -2 | -2 | -2 | -3 | -4 | -2 | -2 | -3 | -3 |
| Share Capital | 10 | 12 | 14 | 15 | 15 | 15 | 15 | 15 | 15 |
Cash Flow
| Cash Flow | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | -1 | -1 | -2 | -1 | -0 | 0 | 0 | 0 | 0 |
| Operating Activities | -0 | -3 | -3 | -1 | -0 | -0 | 1 | -0 | -0 |
| Financing Activities | 1 | 5 | 4 | 2 | 1 | 0 | -1 | 0 | 0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Sept 2025 |
| Promoter | 58.27 % | 58.27 % | 58.27 % | 58.27 % | 52.87 % | 52.87 % | 52.87 % | 52.87 % | 52.87 % | 52.87 % | 52.87 % | 52.87 % | 52.87 % | 52.87 % | 52.87 % | 52.87 % | 49.27 % | 48.25 % | 31.41 % | 31.41 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 36.32 % | 36.32 % | 36.30 % | 36.32 % | 40.24 % | 40.15 % | 40.27 % | 40.68 % | 40.99 % | 40.99 % | 40.97 % | 41.19 % | 41.15 % | 41.12 % | 41.20 % | 41.20 % | 44.75 % | 45.58 % | 64.57 % | 64.54 % |
| Others | 5.41 % | 5.41 % | 5.43 % | 5.41 % | 6.90 % | 6.98 % | 6.86 % | 6.45 % | 6.14 % | 6.14 % | 6.16 % | 5.94 % | 5.99 % | 6.01 % | 5.93 % | 5.93 % | 5.99 % | 6.17 % | 4.02 % | 4.05 % |
| No of Share Holders | 517 | 638 | 653 | 864 | 1,230 | 1,222 | 1,215 | 1,266 | 1,317 | 1,419 | 1,587 | 1,760 | 2,115 | 2,201 | 2,740 | 2,578 | 2,608 | 2,478 | 2,499 | 2,441 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 10 Aug 2022 |  Change Of Name | NA | 10 Aug 2022 | 24.40 | 24.40 |
| 21 Sept 2024 |  Annual General Meeting | NA | 21 Sept 2024 | 17.14 | 27.03 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 20.88 | 20.45 |
| 06 Jan 2025 | Quarterly Result Announcement | NA | 06 Jan 2025 | 22.73 | 22.72 |
| 26 Apr 2025 | Quarterly Result Announcement | NA | 26 Apr 2025 | 14.84 | 18.91 |
| 23 May 2025 |  Extraordinary General Meeting | NA | 23 May 2025 | 20.84 | 20.58 |
| 18 Jul 2025 | Quarterly Result Announcement | NA | 18 Jul 2025 | 19.42 | 17.93 |
| 25 Aug 2025 | Annual General Meeting | NA | 25 Aug 2025 | 17.93 | 20.38 |
| 25 Oct 2025 | Quarterly Result Announcement | NA | 25 Oct 2025 | 19.37 | 20.94 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 27, 2025
Oct 27, 2025Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September 2025Oct 25, 2025
Oct 25, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 25.10.2025Oct 25, 2025
Oct 25, 2025Board Meeting Intimation for Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30Th September 2025Oct 21, 2025
Oct 21, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Appointment of Company Secretary and Compliance OfficerSep 08, 2025
Sep 08, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 08.09.2025Sep 08, 2025
Sep 08, 2025Board Meeting Intimation for Board Meeting Schedule To Be Held On 8Th September 2025Sep 01, 2025
Sep 01, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 25, 2025
Aug 25, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 25, 2025
Aug 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Aug 01, 202529Th Annual General Meeting To Be Held On 25.08.2025Aug 01, 2025
Aug 01, 2025Reg. 34 (1) Annual Report.Jul 31, 2025
Jul 31, 2025Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 29, 2025
Jul 29, 2025Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 28, 2025
Jul 28, 2025Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 28, 2025
Jul 28, 2025Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 28, 2025
Jul 28, 2025Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 23, 2025
Jul 23, 2025Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 23, 2025
Jul 23, 2025Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 23, 2025
Jul 23, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 21, 2025
Jul 21, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 21, 2025
Jul 21, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 21, 2025
Jul 21, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 21, 2025
Jul 21, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 21, 2025
Jul 21, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 21, 2025
Jul 21, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 21, 2025
Jul 21, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesJul 21, 2025
Jul 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 19, 2025
Jul 19, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 18.07.2025Jul 18, 2025
Jul 18, 2025Unaudited Financial Results For Quarter Ended 30.06.2025Jul 18, 2025
Jul 18, 2025Board Meeting Intimation for Board Meeting To Be Held On 18-07-2025 Inter-Alia To Consider Un-Audited Financial Results For The Quarter Ended 30Th June 2025Jul 10, 2025
Jul 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJun 10, 2025
Jun 10, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Re-Constitution Of Committees Of The BoardMay 30, 2025
May 30, 2025Appointment Of New Independent Directors Of The CompanyMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 30, 2025
May 30, 2025Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 30-05-2025May 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationMay 23, 2025
May 23, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 23, 2025
May 23, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 02, 2025
May 02, 2025Submission Of Notice For Extra- Ordinary General Meeting Of The CompanyMay 01, 2025
May 01, 2025Appointment of Company Secretary and Compliance OfficerApr 30, 2025
Apr 30, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 30.04.2025Apr 30, 2025
Apr 30, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Apr 30, 2025Technical Indicators
RSI(14)
Neutral 60.24
ATR(14)
Less Volatile 1.73
STOCH(9,6)
Neutral 70.09
STOCH RSI(14)
Neutral 79.17
MACD(12,26)
Bullish 0.15
ADX(14)
Weak Trend 17.94
UO(9)
Bearish 60.64
ROC(12)
Uptrend And Accelerating 14.41
WillR(14)
Overbought -13.25
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
